GlassScriptPhysician profile
Thomas T German
NPI 1952535452
$2,284.57
in general payments reported to CMS, 2019-2025
31 companies · $619 in 2025
The $619 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $610 · 2023: $363 · 2024: $515 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.74 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $489.61 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $358.88 | 2022-2025 | |
| Novo Nordisk INC | $155.06 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $137.29 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Indivior INC. | $131.74 | 2021-2023 | Sublocade |
| Pfizer INC. | $118.59 | 2023-2025 | |
| Amgen INC. | $82.74 | 2023-2025 | Repatha, Otezla, Repatha |
| Gilead Sciences, INC. | $77.68 | 2022-2024 | |
| Exact Sciences Corporation | $71.52 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $60.70 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $51.35 | 2021-2023 | Proclaim |
| Bayer Healthcare Pharmaceuticals INC. | $51.29 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.62 | 2022 | |
| Braeburn INC. | $45.11 | 2023-2024 | Brixadi |
| Teva Pharmaceuticals USA, INC. | $42.14 | 2023-2025 | Austedo Xr, Austedo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $37.67 | 2022-2025 | Gvoke Hypopen |
| Sunovion Pharmaceuticals INC. | $34.78 | 2021 | |
| Axsome Therapeutics, INC. | $31.18 | 2025 | Symbravo |
| Astrazeneca Pharmaceuticals LP | $31.15 | 2024-2025 | Airsupra, Breztri |
| Corium, LLC | $27.33 | 2025 | Azstarys |
| Merck Sharp & Dohme LLC | $25.09 | 2025 | Capvaxive, Vaxneuvance |
| Vanda Pharmaceuticals INC. | $23.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.35 | 2024 | Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $19.07 | 2024 | Trintellix |
| Astellas Pharma US INC | $18.29 | 2024 | Veozah |
| Inari Medical, INC. | $17.68 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $17.20 | 2022 | |
| Insmed, INC. | $16.24 | 2025 | Arikayce |
| Sanofi-Aventis U.S. LLC | $15.65 | 2024 | |
| Lundbeck LLC | $12.51 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas German listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.